CQC Case Study: Ampersand’s MyIBD Care – Home Monitoring for Patients with IBD
Posted on 05 Aug 2019
The CQC is the independent regulator of health and social care in England. Their purpose is to make sure people are provided with safe, effective, and high-quality care. They have recently published a series of case studies about driving improvement through technology and MyIBD Care has been selected as a new Telemonitoring technology.
Press Release: Ampersand Health launches a new digital therapeutic for people living with Inflammatory Arthritis
19 Jan 2021
Ampersand Health, experts in digital therapeutics for long-term inflammatory conditions, announce the launch of My Arthritis DTx to support people living with...
Ampersand Health’s New Non-Executive Director
24 Jan 2022
Iain Tobin has joined us as a Non-Executive Director, bringing with him his expert knowledge and insight.
Ampersand Health and Versus Arthritis Partner to Transform Digital Arthritis Support
07 Apr 2025
Ampersand Health and Versus Arthritis Announce Strategic Partnership to Transform Digital Support for People Living with Arthritis
US Researchers from University of Michigan & University of Minnesota Evaluate Behaviour Change Techniques in IBD Management Apps
05 Dec 2023
Researchers from The University of Michigan and University of Minnesota Medical School conducted a study titled "Use of Behavior Change Techniques and Quality...
My Arthritis Press Mention in Health Tech Digital
04 Jan 2022
We were featured in Health Tech Digital! We partnered with University Hospitals Dorset NHS Foundation Trust to roll out our My Arthritis App to their patients,...
